7112US Cenp-B (FDA cleared)

Intended Use:

AESKULISA Cenp-B is a solid phase enzyme immunoassay for the quantitative and qualitative detection of IgG antibodies against Cenp-B in human serum.

Recombinant Antigens:

80 kDa Cenp-B

Native Antigens:

n.a.

Kit Configuration

Type: AESKULISA®
Method: Elisa
Reference: 7112US
Description: Cenp-B (FDA cleared)
Kit Configuration: Single - G
Cut Off: 15
Range: 0 - 300 U/ml
Standard: CDC
Antibodies: IgG

Downloads